INFOBIRD CO LTD (IFBD)

KYG477243003 - Common Stock

2.2648  -0.19 (-7.56%)

Fundamental Rating

3

Taking everything into account, IFBD scores 3 out of 10 in our fundamental rating. IFBD was compared to 280 industry peers in the Software industry. While IFBD has a great health rating, there are worries on its profitability. IFBD has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year IFBD has reported negative net income.
IFBD had a negative operating cash flow in the past year.
In multiple years IFBD reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: IFBD reported negative operating cash flow in multiple years.

1.2 Ratios

IFBD has a Return On Assets (-4.47%) which is in line with its industry peers.
The Return On Equity of IFBD (-4.47%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.47%
ROE -4.47%
ROIC N/A
ROA(3y)-48.32%
ROA(5y)-15.28%
ROE(3y)-109.59%
ROE(5y)-27.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

IFBD's Gross Margin of 55.26% is on the low side compared to the rest of the industry. IFBD is outperformed by 67.03% of its industry peers.
IFBD's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for IFBD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.47%
GM growth 5Y1.82%

8

2. Health

2.1 Basic Checks

IFBD does not have a ROIC to compare to the WACC, probably because it is not profitable.
IFBD has more shares outstanding than it did 1 year ago.
IFBD has more shares outstanding than it did 5 years ago.
IFBD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 42.26 indicates that IFBD is not in any danger for bankruptcy at the moment.
The Altman-Z score of IFBD (42.26) is better than 97.07% of its industry peers.
There is no outstanding debt for IFBD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 42.26
ROIC/WACCN/A
WACC10.38%

2.3 Liquidity

IFBD has a Current Ratio of 86.79. This indicates that IFBD is financially healthy and has no problem in meeting its short term obligations.
IFBD's Current ratio of 86.79 is amongst the best of the industry. IFBD outperforms 99.63% of its industry peers.
A Quick Ratio of 86.79 indicates that IFBD has no problem at all paying its short term obligations.
IFBD has a Quick ratio of 86.79. This is amongst the best in the industry. IFBD outperforms 99.63% of its industry peers.
Industry RankSector Rank
Current Ratio 86.79
Quick Ratio 86.79

0

3. Growth

3.1 Past

IFBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.70%, which is quite impressive.
Looking at the last year, IFBD shows a very negative growth in Revenue. The Revenue has decreased by -94.91% in the last year.
Measured over the past years, IFBD shows a very negative growth in Revenue. The Revenue has been decreasing by -56.88% on average per year.
EPS 1Y (TTM)92.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.28%
Revenue 1Y (TTM)-94.91%
Revenue growth 3Y-73.19%
Revenue growth 5Y-56.88%
Sales Q2Q%-90.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

IFBD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for IFBD!.
Industry RankSector Rank
Dividend Yield N/A

INFOBIRD CO LTD

NASDAQ:IFBD (1/8/2025, 8:08:59 PM)

2.2648

-0.19 (-7.56%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)12-13 2022-12-13/bmo
Inst Owners0.45%
Inst Owner Change-0.28%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.51M
Analysts0
Price TargetN/A
Short Float %2.6%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 16.1
P/FCF N/A
P/OCF N/A
P/B 0.08
P/tB 0.08
EV/EBITDA N/A
EPS(TTM)-162.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.37
FCFYN/A
OCF(TTM)-1.37
OCFYN/A
SpS0.14
BVpS28.94
TBVpS28.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.47%
ROE -4.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.26%
FCFM N/A
ROA(3y)-48.32%
ROA(5y)-15.28%
ROE(3y)-109.59%
ROE(5y)-27.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.47%
GM growth 5Y1.82%
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 86.79
Quick Ratio 86.79
Altman-Z 42.26
F-Score4
WACC10.38%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-94.91%
Revenue growth 3Y-73.19%
Revenue growth 5Y-56.88%
Sales Q2Q%-90.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.03%
OCF growth 3YN/A
OCF growth 5YN/A